New 'mutation-tracking' blood test could predict breast cancer relapse months in advance

Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumors are visible on hospital scans.The test can uncover small numbers of residual cancer cells that have resisted therapy by detecting cancer DNA in the bloodstream.

Read the whole article on Science Daily

More from Science Daily